Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation

NCT01243008 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Lyme Disease

Interventions

DRUG: Application of SHB001

Sponsor

University of Zurich

Collaborators

[object Object]
[object Object]